BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6698577)

  • 21. Complement component C5: engineering of a mutant that is specifically cleaved by the C4-specific C1s protease.
    Ogata RT; Low PJ
    J Immunol; 1995 Sep; 155(5):2642-51. PubMed ID: 7650393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A study on the location of synthetic sites of the fourth and fifth components of the complement system in allogeneic bone marrow chimeras and hepatocyte transplantation chimeras].
    Geng L
    Hokkaido Igaku Zasshi; 1986 Mar; 61(2):289-97. PubMed ID: 3522387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preparation of lyophilized reagents for determining the functional activity of complement C1, C2, C3, C4 and C5 components].
    Nikiforova TV; Kuznetsova NN; Vavilova LM
    Lab Delo; 1988; (3):28-31. PubMed ID: 2453712
    [No Abstract]   [Full Text] [Related]  

  • 24. Isolation of C4-binding protein from guinea pig plasma and demonstration of its function as a control protein of the classical complement pathway C3 convertase.
    Burge J; Nicholson-Weller A; Austen KF
    J Immunol; 1981 Jan; 126(1):232-5. PubMed ID: 6778916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between the labile binding sites of the fourth (C4) and fifth (C5) human complement proteins and erythrocyte cell membranes.
    Law SK; Lichtenberg NA; Holcombe FH; Levine RP
    J Immunol; 1980 Aug; 125(2):634-9. PubMed ID: 7391573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Murine C4-binding protein: a rapid purification method by affinity chromatography.
    Kaidoh T; Natsuume-Sakai S; Takahashi M
    J Immunol; 1981 Feb; 126(2):463-7. PubMed ID: 6161173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Separation of six bovine complement components and one inactivator (1, 2).
    Barta O; Nelson RA; Kuo CY
    Immunol Commun; 1976; 5(1-2):75-86. PubMed ID: 950248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and characterization of the third component of rat complement.
    Daha MR; Stuffers-Heiman M; Kijlstra A; van Es LA
    Immunology; 1979 Jan; 36(1):63-70. PubMed ID: 422228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and characterisation of the fourth component of bovine complement.
    Groth DM; Wetherall JD; Umotong BA; Sparrow P; Lee IR; Carrick MJ
    Complement; 1987; 4(1):1-11. PubMed ID: 3568627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparison of consumption kinetics of the C4 and C2 components of complement by immune complexes "in vitro" (author's transl)].
    Roncato M; Maillet F; Peltier AP
    Pathol Biol (Paris); 1981 Feb; 29(2):95-9. PubMed ID: 7015243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of HIV-1 protease cleavage site in human C1-inhibitor.
    Gerencer M; Burek V
    Virus Res; 2004 Sep; 105(1):97-100. PubMed ID: 15325085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Components of human complement system. Testing and isolation of C4].
    Chikh VP; Kosiak AV; Shukun SA; Surovtsev VI
    Biokhimiia; 1990 Mar; 55(3):404-7. PubMed ID: 2354211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification of the third and fifth components of human complement: application of hydrophobic chromatography.
    Kunkel SL; Kreutzer DL; Goralnick S; Ward PA
    J Immunol Methods; 1980; 35(3-4):337-51. PubMed ID: 7400588
    [No Abstract]   [Full Text] [Related]  

  • 34. A 100-kDa protein in the C4-activating component of Ra-reactive factor is a new serine protease having module organization similar to C1r and C1s.
    Takayama Y; Takada F; Takahashi A; Kawakami M
    J Immunol; 1994 Mar; 152(5):2308-16. PubMed ID: 8133044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. C1, C4, and C2 components of the classical pathway of complement and regulatory proteins.
    Gigli I; Tausk FA
    Methods Enzymol; 1988; 162():626-39. PubMed ID: 3226327
    [No Abstract]   [Full Text] [Related]  

  • 36. Structural analysis of chicken factor B-like protease and comparison with mammalian complement proteins factor B and C2.
    Kjalke M; Welinder KG; Koch C
    J Immunol; 1993 Oct; 151(8):4147-52. PubMed ID: 8409391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large scale isolation of functionally active components of the human complement system.
    Hammer CH; Wirtz GH; Renfer L; Gresham HD; Tack BF
    J Biol Chem; 1981 Apr; 256(8):3995-4006. PubMed ID: 6783652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of functional recombinant von Willebrand factor-A domain from human complement C2: a potential binding site for C4 and CRIT.
    Hui KM; Orriss GL; Schirmer T; Magnadóttir B; Schifferli JA; Inal JM
    Biochem J; 2005 Aug; 389(Pt 3):863-8. PubMed ID: 15823096
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Separation of functionally or highly pure C2 from human plasma with Sepharose and a lectin of Euonymus europeus.
    Schultz DR; Arnold PI
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():59-66. PubMed ID: 6587744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation, characterization and utilization of the fifth component (C5) of porcine complement.
    Vĕtvicka V; Zídková J; Fornůsek L; Ríhová B
    Folia Biol (Praha); 1986; 32(3):195-208. PubMed ID: 2943607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.